Photodynamic therapy: improving survival and quality of life for patients with non-resectable cholangiocarcinoma

Mundy L, Merlin T
Record ID 32006000561
English
Authors' results and conclusions: There is limited Level II and Level IV evidence. However, given that it is an established technology in Australia, it is expected that photodynamic therapy (PDT) for non-resectable cholangiocarcinoma would diffuse rapidly into the Australian health system.
Authors' recommendations: HealthPACT recommends that this technology be monitored.
Details
Project Status: Completed
Year Published: 2003
URL for published report: Not Available
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Australia
MeSH Terms
  • Photochemotherapy
  • Quality of Life
  • Survival Rate
  • Bile Duct Neoplasms
  • Cholangiocarcinoma
  • Photosensitizing Agents
Contact
Organisation Name: Adelaide Health Technology Assessment
Contact Address: School of Public Health, Mail Drop 545, University of Adelaide, Adelaide SA 5005, AUSTRALIA, Tel: +61 8 8313 4617
Contact Name: ahta@adelaide.edu.au
Contact Email: ahta@adelaide.edu.au
Copyright: Adelaide Health Technology Assessment (AHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.